NC
Nilkanth Chandulal Thakkar
About Nilkanth Chandulal Thakkar
Data last updated:
Nilkanth Chandulal Thakkar is a Director at Akshar Global Clinical Research Private Limited (since 2023), Director at Prm Refractories & Metals Private Limited (since 2018) and Director at Alevigen Biosciences Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Professional Services, Manufacturing and Biotechnology. The 2 current companies with reported revenue have a combined latest revenue of ₹16,750; the largest is Akshar Global Clinical Research Private Limited at ₹10,000 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 May 2023 | 2023 | ₹10,000 (FY 2024) | Active | |
| Director | 24 Aug 2018 | 2018 | ₹6,750 (FY 2025) | Active | |
| Director | 02 Jan 2026 | 2026 | Active | ||
| Director | 26 Mar 2025 | 2025 | Active |
Board colleagues of Nilkanth Chandulal Thakkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bansal Atulkumar Thakkar | 10169651 | Akshar Global Clinical Research Private Limited , Alevigen Biosciences Private Limited | Director |
| Mangesh Sukhdeorao Shende | 10762536 | Akshar Global Clinical Research Private Limited | Director |
| Raj Bipinbhai Thakkar | 11394154 | Akshar Global Clinical Research Private Limited , Alevigen Biosciences Private Limited | Additional Director |
| Rekhaben Thakkar | 08872298 | Prm Refractories & Metals Private Limited , Pramukh Global Organics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilkanth Chandulal Thakkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilkanth Chandulal Thakkar
Nilkanth Chandulal Thakkar currently holds 4 directorships: Akshar Global Clinical Research Private Limited (Director, since 18 May 2023, revenue ₹10,000 (FY 2024)); Prm Refractories & Metals Private Limited (Director, since 24 Aug 2018, revenue ₹6,750 (FY 2025)); Alevigen Biosciences Private Limited (Director, since 02 Jan 2026); Pramukh Global Organics Private Limited (Director, since 26 Mar 2025).
Nilkanth Chandulal Thakkar was first appointed on 24 Aug 2018 as Director at Prm Refractories & Metals Private Limited. The most recent appointment on record is 02 Jan 2026 at Alevigen Biosciences Private Limited.
The 2 current companies of Nilkanth Chandulal Thakkar that report revenue have a combined latest revenue of ₹16,750: Akshar Global Clinical Research Private Limited ₹10,000 (FY 2024); Prm Refractories & Metals Private Limited ₹6,750 (FY 2025).
The current boards of Nilkanth Chandulal Thakkar's companies include Bansal Atulkumar Thakkar (Akshar Global Clinical Research Private Limited), Mangesh Sukhdeorao Shende (Akshar Global Clinical Research Private Limited), Raj Bipinbhai Thakkar (Akshar Global Clinical Research Private Limited), Rekhaben Thakkar (Prm Refractories & Metals Private Limited).